首页> 外国专利> OLIGOPEPTIDE FORMED BY COMBINING TARGETED EPS8 WITH EGFR AND USES THEREOF

OLIGOPEPTIDE FORMED BY COMBINING TARGETED EPS8 WITH EGFR AND USES THEREOF

机译:通过将靶向的EPS8与EGFR结合而形成的寡肽及其用途

摘要

Disclosed are an oligopeptide formed by combining targeted EPS8 with EGFR and uses thereof. The sequence of the oligopeptide is N'-Arg-Lys-Lys-Asn-Lys-Pro-Pro-Pro-Pro-Lys-Lys-C'. The oligopeptide is capable of effectively inhibiting EPS8 positive tumor proliferation, can be used for preparing medicaments for treating EPS8 positive tumors, and has huge potential of being developed into anti-tumor peptide drugs.
机译:公开了通过将靶向的EPS8与EGFR结合形成的寡肽及其用途。寡肽的序列是N'-Arg-Lys-Lys-Asn-Lys-Pro-Pro-Pro-Pro-Lys-Lys-C'。该寡肽能够有效抑制EPS8阳性肿瘤的增殖,可用于制备治疗EPS8阳性肿瘤的药物,具有开发抗肿瘤肽的巨大潜力。

著录项

  • 公开/公告号WO2015172563A1

    专利类型

  • 公开/公告日2015-11-19

    原文格式PDF

  • 申请/专利权人 SOUTHERN MEDICAL UNIVERSITY;

    申请/专利号WO2014CN94896

  • 发明设计人 LI YUHUA;XUE TONGYUAN;

    申请日2014-12-25

  • 分类号C07K7/06;A61K38/08;A61P35;

  • 国家 WO

  • 入库时间 2022-08-21 14:20:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号